Recent Finacing
Recent Raise
TargED develops Microlyse, a VhH single-domain antibody–guided thrombolytic that binds thrombosis-specific protein to deliver an enzyme to clots, advancing toward clinical studies for aTTP and acute ischemic stroke.
Recent Investors
Total Raised
Funding round
Investors